Drug shortages in the United States: A critical evaluation of root causes and the need for action

Clinical Pharmacology and Therapeutics

Volumn 93, Issue 2, 2013, Pages 133-135

  Gupta, D K ^a   Huang, S M ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIINFECTIVE AGENT;

ANTIMICROBIAL THERAPY; CLINICAL PHARMACOLOGY; DRUG MANUFACTURE; DRUG SHORTAGE; ECONOMIC EVALUATION; FOOD AND DRUG ADMINISTRATION; GOOD MANUFACTURING PRACTICE; HEALTH CARE DISTRIBUTION; HEALTH CARE MANAGEMENT; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REIMBURSEMENT; REVIEW; UNITED STATES;

DRUG INDUSTRY; HUMANS; PHARMACEUTICAL PREPARATIONS; ROOT CAUSE ANALYSIS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84872736967     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2012.229     Document Type: Review

References (11)

1. Fox, E.R. & Tyler, L.S. Call to action: finding solutions for the drug shortage crisis in the United States. Clin. Pharmacol. Ther. 93, 145-147 (2013).
2. Teagarden, J.R. & Epstein, R.S. Pharmacy benefit managers and their obligations during serious prescription drug shortages. Clin. Pharmacol. Ther. 93, 143-145 (2013)
3. Gatesman, M.L. & Smith, T.J. The shortage of essential chemotherapy drugs in the United States. N. Engl. J. Med. 365, 1653-1655 (2011).
4. Toh, S., Platt, R., Steiner, J.F. & Brown, J.S. Comparative- effectiveness research in distributed health data networks. Clin. Pharmacol. Ther. 90, 883-887 (2011).
5. Lalonde, R.L. & Willke, R.J. Comparative efficacy and effectiveness: an opportunity for clinical pharmacology. Clin. Pharmacol. Ther. 90, 761-763 (2011).
6. Huang, S.-M., Bhattaram, A., Mehrotra, N. & Wang, Y. Is this the dose for you?: the role of modeling. Clin. Pharmacol. Ther. 93, 159-162 (2013).
7. Yang, R., Niepel, M., Mitchison, T.K. & Sorger, P.K. Dissecting variability in responses to cancer chemotherapy through systems pharmacology. Clin. Pharmacol. Ther. 88, 34-38 (2010).
8. Woodcock, J. & Wosinska, M. Economic and technological drivers of generic sterile injectable drug shortages. Clin. Pharmacol. Ther. 93, 170-176 (2013).
9. Woodcock, J. Reliable drug quality: an unresolved problem. PDA J. Pharm. Sci. Technol. 66, 270-272 (2012).
10. Kweder, S.L. & Dill, S. Drug shortages: the cycle of quantity and quality. Clin. Pharmacol. Ther. (in press).
11. Outterson, K. Regulating compounding pharmacies after NECC. N. Engl. J. Med. 367, 1969-1972 (2012).